Erratum: Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors

Erratum: Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors

Correction to: British Journal of Cancer (2013) 109, 60–67. doi:10.1038/bjc.2013.226 Since the advance online publication of this paper in May 2013, the authors realised that fresh calculations of the cohort of testicular cancer patients were required after omitting nine patients who received radiot...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of cancer 2013-07, Vol.109 (1), p.295-296
Hauptverfasser: Willemse, P M, Burggraaf, J, Hamdy, N A T, Weijl, N I, Vossen, C Y, van Wulften, L, van Steijn-van Tol, A Q M J, Rosendaal, F R, Osanto, S
Format: Artikel
Sprache:eng
Schlagworte:
692/699/2743/2037
692/699/67/1059/99
692/699/67/1836
Biomedical and Life Sciences
Biomedicine
Cancer Research
corrigendum
Drug Resistance
Epidemiology
Erratum
Molecular Medicine
Oncology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Correction to: British Journal of Cancer (2013) 109, 60–67. doi:10.1038/bjc.2013.226 Since the advance online publication of this paper in May 2013, the authors realised that fresh calculations of the cohort of testicular cancer patients were required after omitting nine patients who received radiotherapy.
ISSN:0007-0920
1532-1827
DOI:10.1038/bjc.2013.358